loading

Finanzdaten der Engene Holdings Inc-Aktie (ENGN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-01-31 2025-04-30 2024-07-31 2024-04-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - -
Operating Expenses
1.88%
26.61
27.12 16.76 17.31
Operating Income/Loss
1.88%
-26.61
-27.12 -16.76 -17.31
Nonoperating Income/Loss
30.08%
2.015
1.549 2.582 2.347
Income/Loss From Continuing Operations Before Tax
3.82%
-24.60
-25.57 -14.18 -14.96
Income Tax Expense/Benefit
92.50%
0.018
0.24 -0.029 0.021
Income/Loss From Continuing Operations After Tax
4.64%
-24.62
-25.82 -14.15 -14.98
Net Income/Loss
4.64%
-24.62
-25.82 -14.15 -14.98
Preferred Stock Dividends And Other Adjustments
-
- - -
Attributable To Noncontrolling Interest
-
- - -
Basic Average Shares
0.08%
50.98
51.02 44.17 39.44
Diluted Average Shares
0.08%
50.98
51.02 44.17 39.44
Basic Earnings Per Share
5.88%
0.48
0.51 0.32 0.38
Diluted Earnings Per Share
5.88%
0.48
0.51 0.32 0.38
Common Stock Dividends
-
- - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -
$39.05
price down icon 0.29%
$31.89
price down icon 0.34%
$100.21
price down icon 0.18%
$96.34
price up icon 0.67%
biotechnology ONC
$319.27
price down icon 3.53%
$205.23
price up icon 0.18%
Kapitalisierung:     |  Volumen (24h):